Royal Bank of Canada’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-1,894
Closed -$16K 6532
2013
Q3
$16K Sell
1,894
-207,212
-99% -$1.31M ﹤0.01% 5268
2013
Q2
$860K Buy
+209,106
New +$1.12M ﹤0.01% 2697

Royal Bank of Canada's ASTX Position: Q4 2013 in Review

Royal Bank of Canada sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 1,894 shares — an estimated $16K sold.

Royal Bank of Canada first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $860K in Q2 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Royal Bank of Canada reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Royal Bank of Canada sold 1,894 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $16K.
  • Royal Bank of Canada first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Royal Bank of Canada's ASTEX PHARMACEUTICALS, INC COM position peaked at $860K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Royal Bank of Canada's 13F filing for Q4 2013, filed 14 Feb 2014.